159 related articles for article (PubMed ID: 18289100)
21. [Association of hepatic iron deposition and serum iron indices with hepatic inflammation and fibrosis stage in nonalcoholic fatty liver disease].
Moon JH; Park SH; Oh KC; Jung JO; Shin WG; Kim JP; Kim KO; Park CH; Hahn T; Yoo KS; Kim JH; Kim DJ; Lee MS; Park CK; Jun SY
Korean J Gastroenterol; 2006 Jun; 47(6):432-9. PubMed ID: 16809950
[TBL] [Abstract][Full Text] [Related]
22. Iron-induced liver injury.
Bonkovsky HL; Lambrecht RW
Clin Liver Dis; 2000 May; 4(2):409-29, vi-vii. PubMed ID: 11232198
[TBL] [Abstract][Full Text] [Related]
23. [Non-alcoholic steatohepatitis].
Haukeland JW; Konopski Z; Bell H; Raknerud N
Tidsskr Nor Laegeforen; 2001 Aug; 121(20):2377-80. PubMed ID: 11603045
[TBL] [Abstract][Full Text] [Related]
24. [Nonalcoholic steatohepatitis. Three case reports].
Eivindson MV; Hamilton-Dutoit S; Grønbaek H
Ugeskr Laeger; 2003 Mar; 165(11):1118-20. PubMed ID: 12677986
[TBL] [Abstract][Full Text] [Related]
25. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.
Bugianesi E; Manzini P; D'Antico S; Vanni E; Longo F; Leone N; Massarenti P; Piga A; Marchesini G; Rizzetto M
Hepatology; 2004 Jan; 39(1):179-87. PubMed ID: 14752836
[TBL] [Abstract][Full Text] [Related]
26. Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.
Manne V; Handa P; Kowdley KV
Clin Liver Dis; 2018 Feb; 22(1):23-37. PubMed ID: 29128059
[TBL] [Abstract][Full Text] [Related]
27. Non-alcoholic steatohepatitis and metabolic syndrome.
Machado M; Cortez-Pinto H
Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):637-42. PubMed ID: 16912563
[TBL] [Abstract][Full Text] [Related]
28. [The role of iron overload in the progression of nonalcoholic steatohepatitis (NASH)].
Atarashi M; Izawa T; Kuwamura M; Yamate J
Nihon Yakurigaku Zasshi; 2019; 154(2):61-65. PubMed ID: 31406044
[TBL] [Abstract][Full Text] [Related]
29. Fibrosis in alcoholic and nonalcoholic steatohepatitis.
Bataller R; Rombouts K; Altamirano J; Marra F
Best Pract Res Clin Gastroenterol; 2011 Apr; 25(2):231-44. PubMed ID: 21497741
[TBL] [Abstract][Full Text] [Related]
30. Iron Overload in the Liver of 2 Children: Nonalcoholic Steatohepatitis and Juvenile Hemochromatosis.
Ünlüsoy Aksu A; Caleffi A; Pietrangelo A; Sari S; Eğritaş Gürkan Ö; Demirtaş Z; Yilmaz G; Dalgiç B
J Pediatr Hematol Oncol; 2017 Aug; 39(6):466-469. PubMed ID: 28067690
[TBL] [Abstract][Full Text] [Related]
31. Steatohepatitis is developed by a diet high in fat, sucrose, and cholesterol without increasing iron concentration in rat liver.
Takai K; Funaba M; Matsui T
Biol Trace Elem Res; 2016 Apr; 170(2):401-9. PubMed ID: 26340976
[TBL] [Abstract][Full Text] [Related]
32. Iron overload and non-alcoholic fatty liver disease.
Datz C; Müller E; Aigner E
Minerva Endocrinol; 2017 Jun; 42(2):173-183. PubMed ID: 27834478
[TBL] [Abstract][Full Text] [Related]
33. Iron and HFE mutations in nonalcoholic steatohepatitis: innocent bystanders or accessories to the crime?
Bhattacharya R; Kowdley KV
Gastroenterology; 2003 Aug; 125(2):615-6; discussion 617. PubMed ID: 12891567
[No Abstract] [Full Text] [Related]
34. Nonalcoholic steatohepatitis.
Brunt EM
Semin Liver Dis; 2004 Feb; 24(1):3-20. PubMed ID: 15085483
[TBL] [Abstract][Full Text] [Related]
35. Iron and non-alcoholic fatty liver disease.
Britton LJ; Subramaniam VN; Crawford DH
World J Gastroenterol; 2016 Sep; 22(36):8112-22. PubMed ID: 27688653
[TBL] [Abstract][Full Text] [Related]
36. High-fat, high-fructose diet induces hepatic iron overload via a hepcidin-independent mechanism prior to the onset of liver steatosis and insulin resistance in mice.
Tsuchiya H; Ebata Y; Sakabe T; Hama S; Kogure K; Shiota G
Metabolism; 2013 Jan; 62(1):62-9. PubMed ID: 22854109
[TBL] [Abstract][Full Text] [Related]
37. Iron overload results in hepatic oxidative stress, immune cell activation, and hepatocellular ballooning injury, leading to nonalcoholic steatohepatitis in genetically obese mice.
Handa P; Morgan-Stevenson V; Maliken BD; Nelson JE; Washington S; Westerman M; Yeh MM; Kowdley KV
Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(2):G117-27. PubMed ID: 26564716
[TBL] [Abstract][Full Text] [Related]
38. The Role of Iron and Iron Overload in Chronic Liver Disease.
Milic S; Mikolasevic I; Orlic L; Devcic E; Starcevic-Cizmarevic N; Stimac D; Kapovic M; Ristic S
Med Sci Monit; 2016 Jun; 22():2144-51. PubMed ID: 27332079
[TBL] [Abstract][Full Text] [Related]
39. Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease.
Marmur J; Beshara S; Eggertsen G; Onelöv L; Albiin N; Danielsson O; Hultcrantz R; Stål P
BMC Gastroenterol; 2018 Jun; 18(1):78. PubMed ID: 29871592
[TBL] [Abstract][Full Text] [Related]
40. Iron absorption in nonalcoholic steatohepatitis and dysmetabolic iron overload syndrome.
Ruivard M; Laine F; Deugnier Y
Hepatology; 2016 May; 63(5):1737-8. PubMed ID: 26476299
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
